MIPS Molecular Imaging Program at Stanford

Research Associates

Qizhen Cao, PhD

Qizhen Cao, PhD

Research Associate, Cancer Molecular Imaging Chemistry Laboratory (CMICL)

Awards:

2006 Dean's Fellowship - Stanford University. Fellowship awarded for work on "Combined Integrin siRNA Therapy and Radiotherapy of Breast Cancer".
2008-2010 TRDRP Fellowship - California, Fellowship awarded for work on lung cancer imaging and therapy.
2009 SNM travel award


Contact Information:

Molecular Imaging Program at Stanford
Lucas Expansion, P087
1201 Welch Road
Stanford, CA 94305-5484

Phone: 650-736-0202
Fax: 650-736-7925
E-mail: qzhcao@stanford.edu


Recent Publications:

  1. Liu Z, Li ZB, Cao Q, Liu S, Wang F, Chen X. . Small-Animal PET of Tumors with 64Cu-Labeled RGD-Bombesin Heterodimer. J Nucl Med. 2009;50(7):1168-1177.
  2. Niu G, Li Z, Cao Q, Chen X. Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with (64)Cu-DOTA-trastuzumab. Eur J Nucl Med Mol Imaging. 2009;36(9):1510-1519.
  3. Cao Q, Cai W, Niu G, He L, Chen X. Multimodality Imaging of IL-18bp-Fc Therapy of Experimental Lung Metastasis. Clin Cancer Res. 2008;14(19):6137-6145.
  4. Cao Q, Li Z-B, Chen K, Wu Z, He L, Neamati N, Chen X. Evaluation of Biodistribution and Anti-tumor Effect of a Dimeric RGD Peptide-paclitaxel Conjugate in Mice with Breast Cancer. Eur J Nucl Med Mol Imaging. 2008;35(8):1489-1498.
  5. Liu Z, Chen K, Davis C, Sherlock S, Cao Q, Chen X, Dai H. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res.. 2008;68(16):6552-6560.
  6. Cai W, Chen K, He L, Cao Q, Koong A, Chen X. Quantitative PET imaging of EGFR expression in xenograft-bearing mice using 64Cu-labeled Cetuximab, a chimeric anti-EGFR monoclonal antibody . Eur. J. Nucl. Med. Mol. Imaging. 2007;34(6):850-8.
  7. Cai W, Ebrahimnejad A, Chen K, Cao Q, Li ZB, Tice DA, Chen X. Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice. Eur. J. Nucl. Med. Mol. Imaging. 2007;34(12):2024-2036.
  8. Cai W, Olafsen T, Zhang X, Cao Q, Gambhir SS, Williams LE, Wu AM, Chen X. Positron Emission Tomography Imaging of Colorectal Cancer in Xenograft-Bearing Mice Using 18F-Labeled T84.66 Anti-CEA Diabody. J. Nucl. Med.. 2007;48:304-310.
  9. Cao Q, Cai W, Li Z-B, Chen K, He L, Li H-C, Hui M, Chen X. PET of Acute and Chronic Inflammation in Living Mice. Eur J Nucl Med Mol Imaging. 2007;34(11):1832-1842.
  10. Li Z-B, Cai W, Cao Q, Chen K, Wu Z, He L, Chen X. 64Cu-Labeled Tetrameric and Octameric RGD Peptides for MicroPET Imaging of Tumor alpha(v)beta(3) Integrin Expression . J Nucl Med. 2007;48(7):1162-1171.
  11. Li Z-B, Cai W, Cao Q, Chen K, Wu Z, He L, Chen X. 64Cu-Labeled Tetrameric and Octameric RGD Peptides for MicroPET Imaging of Tumor alpha(v)beta(3) Integrin Expression. J Nucl Med. 2007;48(7):1162-1171.
  12. Li Z-B, Wu Z, Cao Q, Dick WD, Tseng RJ, Gambhir SS, Chen X. Brain Tumor Imaging with 18F-2-Fluorodeoxysorbitol (18F-FDS). Mol Imaging Biol. 2007;Dec 21:Epub.
  13. Wang J, Yang CT, Kim YS, Sreerama SG, Cao Q, Li ZB, He Z, Chen X, Liu S.. (64)Cu-Labeled Triphenylphosphonium and Triphenylarsonium Cations as Highly Tumor-Selective Imaging Agents.. J Med Chem.. 2007;50(21):5057-5069.
  14. Cai W, Shin D-W, Wu Y, Cao Q, Gheysens O, Gambhir SS, Wang SX, Chen X. Peptide-labeled NIR quantum dot for cancer imaging in vivo. Nano Letters. 2006;6():669-676.
  15. Cai W, Wu Y, Chen K, Cao Q, Tice DA, Chen X. In vitro and in vivo characterization of 64Cu-labeled AbegrinTM, a humanized monoclonal antibody against integrin avb3. Cancer Res.. 2006;66:9673-9681.
  16. Cao Q, Cai W, Li T, Yang Y, Chen K, Xing L, Chen X. Combination of integrin siRNA and irradiation for breast cancer therapy. Biochem. Biophys. Res. Commun.. 2006;351:726-732.

Stanford Medicine Resources:

Footer Links: